PT81490A - Process for preparing a novel crystalline form of benzothiazine dioxide monoethanolamine salt - Google Patents

Process for preparing a novel crystalline form of benzothiazine dioxide monoethanolamine salt

Info

Publication number
PT81490A
PT81490A PT81490A PT8149085A PT81490A PT 81490 A PT81490 A PT 81490A PT 81490 A PT81490 A PT 81490A PT 8149085 A PT8149085 A PT 8149085A PT 81490 A PT81490 A PT 81490A
Authority
PT
Portugal
Prior art keywords
crystalline form
novel crystalline
preparing
monoethanolamine salt
benzothiazine dioxide
Prior art date
Application number
PT81490A
Other languages
English (en)
Other versions
PT81490B (pt
Inventor
Robert Lee Robertson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT81490A publication Critical patent/PT81490A/pt
Publication of PT81490B publication Critical patent/PT81490B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L57/00—Protection of pipes or objects of similar shape against external or internal damage or wear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
PT81490A 1984-11-16 1985-11-14 Processo para a preparacao de uma nova forma cristalina do sal monoetanolamina de dioxidos de benzotiazinas PT81490B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/672,028 US4582831A (en) 1984-11-16 1984-11-16 Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor

Publications (2)

Publication Number Publication Date
PT81490A true PT81490A (en) 1985-12-01
PT81490B PT81490B (pt) 1988-03-03

Family

ID=24696846

Family Applications (1)

Application Number Title Priority Date Filing Date
PT81490A PT81490B (pt) 1984-11-16 1985-11-14 Processo para a preparacao de uma nova forma cristalina do sal monoetanolamina de dioxidos de benzotiazinas

Country Status (28)

Country Link
US (1) US4582831A (pt)
EP (1) EP0182572B1 (pt)
JP (1) JPS61122284A (pt)
KR (1) KR870000291B1 (pt)
CN (1) CN1004001B (pt)
AT (1) ATE50257T1 (pt)
AU (1) AU556378B2 (pt)
CA (1) CA1209572A (pt)
DD (1) DD242405A5 (pt)
DE (1) DE3575925D1 (pt)
DK (1) DK171726B1 (pt)
EG (1) EG17621A (pt)
ES (1) ES8701712A1 (pt)
FI (1) FI82045C (pt)
GR (1) GR852772B (pt)
HU (1) HU197899B (pt)
IE (1) IE58288B1 (pt)
IL (1) IL77051A (pt)
IN (1) IN164207B (pt)
MY (1) MY101984A (pt)
NO (1) NO854574L (pt)
NZ (1) NZ214201A (pt)
PH (1) PH21322A (pt)
PL (1) PL149466B1 (pt)
PT (1) PT81490B (pt)
SU (1) SU1491339A3 (pt)
YU (1) YU44019B (pt)
ZA (1) ZA858773B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
US20030068829A1 (en) * 2001-06-25 2003-04-10 Symyx Technologies, Inc. High throughput crystallographic screening of materials
TWI280128B (en) 2002-05-22 2007-05-01 Smithkline Beecham Corp 3'-[(2Z)-[1-(3,4- dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
ECSP077628A (es) * 2007-05-03 2008-12-30 Smithkline Beechman Corp Nueva composición farmacéutica
WO2010138656A1 (en) 2009-05-29 2010-12-02 Glaxosmithkline Llc Methods of administration of thrombopoietin agonist compounds
CN103626777B (zh) * 2009-07-29 2015-10-21 内尔维阿诺医学科学有限公司 Plk抑制剂的盐类
GB0914287D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
IN160683B (pt) * 1981-06-01 1987-07-25 Pfizer
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
RO88420A (ro) * 1983-04-25 1986-01-30 Pfizer Inc,Us Procedeu pentru prepararea unor saruri bazice de piroxican depuse pe suporturi farmaceutice

Also Published As

Publication number Publication date
GR852772B (pt) 1986-03-14
KR870000291B1 (ko) 1987-02-25
MY101984A (en) 1992-02-29
JPH0425957B2 (pt) 1992-05-06
EG17621A (en) 1991-08-30
PL149466B1 (en) 1990-02-28
DK171726B1 (da) 1997-04-14
AU4995085A (en) 1986-05-22
FI854512A0 (fi) 1985-11-15
ATE50257T1 (de) 1990-02-15
IL77051A (en) 1989-03-31
DD242405A5 (de) 1987-01-28
IE58288B1 (en) 1993-08-25
CN85108245A (zh) 1986-09-03
FI82045B (fi) 1990-09-28
DK527585D0 (da) 1985-11-15
IN164207B (pt) 1989-01-28
PT81490B (pt) 1988-03-03
KR860004038A (ko) 1986-06-16
SU1491339A3 (ru) 1989-06-30
ZA858773B (en) 1987-06-24
HU197899B (en) 1989-06-28
DK527585A (da) 1986-05-17
IL77051A0 (en) 1986-04-29
EP0182572A1 (en) 1986-05-28
CN1004001B (zh) 1989-04-26
PH21322A (en) 1987-09-28
AU556378B2 (en) 1986-10-30
JPS61122284A (ja) 1986-06-10
NO854574L (no) 1986-05-20
EP0182572B1 (en) 1990-02-07
DE3575925D1 (de) 1990-03-15
ES548878A0 (es) 1986-12-01
ES8701712A1 (es) 1986-12-01
YU178585A (en) 1987-12-31
US4582831A (en) 1986-04-15
YU44019B (en) 1990-02-28
HUT40116A (en) 1986-11-28
IE852852L (en) 1986-05-16
FI854512A (fi) 1986-05-17
NZ214201A (en) 1988-07-28
FI82045C (fi) 1991-01-10
CA1209572A (en) 1986-08-12
PL256259A1 (en) 1986-10-07

Similar Documents

Publication Publication Date Title
AU580355B2 (en) N-((4,6-dimethoxypyrimidin-2-YL)Aminocarbonyl)-3- trifluoromethylpridine-2-sulfonamide or salts thereof, herbicidal composition containing the same, and process for the production of the compound
IE870610L (en) Hydroxylamine derivatives.
IE821286L (en) Crystalline benzothiazine dioxide salts
EG17391A (en) Process for preparing 2-(n-substituted guanidino)-4-heteroarylthiazole antiulcer agents
CS38989A2 (en) Method of phenoxyacetamidoderivative production
PT81490A (en) Process for preparing a novel crystalline form of benzothiazine dioxide monoethanolamine salt
GB2146982B (en) New 1,3,4-thiadiazole derivatives process for the production thereof and pharmaceutical compositions having antiulcer activity containing the same
DE3473443D1 (en) New amino derivatives of 2- (n-(2,2,5,5-tetramethyl-3-pyrrolin-or pyrrolidine-3-carbonyl))
PT76077A (en) Process for preparing 6-aminoalkylpenicillanic acid 1,1-dioxides and derivatives as beta-lactamase inhibitors
DE3466877D1 (en) Crystalline salts of l or (s)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process
CS410788A1 (en) Method of n-(1-formamido-2,2,2-trichlorethyl)morpholine's crystalline modification production
YU148283A (en) Process for the manufcture of n-(2-pyrridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide
YU72283A (en) Process for the manufcture of n-(2-pyrridyl)-2-alkyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide
YU202183A (en) Process for the manufacture of n-(2-pyridil)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20050317